|
Originally published In Press as doi:10.1074/jbc.M213168200 on January 30, 2003
J. Biol. Chem., Vol. 278, Issue 15, 13196-13206, April 11, 2003
Photoaffinity Labeling with a Neuroactive Steroid Analogue
6-AZI-PREGNANOLONE LABELS VOLTAGE-DEPENDENT ANION
CHANNEL-1 IN RAT BRAIN*
Ramin
Darbandi-Tonkabon ,
William R.
Hastings ,
Chun-Min
Zeng§,
Gustav
Akk ,
Brad D.
Manion ,
John R.
Bracamontes ,
Joseph H.
Steinbach ,
Steven J.
Mennerick¶,
Douglas F.
Covey§, and
Alex S.
Evers §
From the Departments of Anesthesiology,
§ Molecular Biology and Pharmacology, and ¶ Psychiatry,
Washington University School of Medicine, St. Louis, Missouri 63110
Neuroactive steroids modulate the function
of -aminobutyric acid, type A (GABAA) receptors in
the central nervous system by an unknown mechanism. In this study we
have used a novel neuroactive steroid analogue,
3 ,5 -6-azi-3-hydroxypregnan-20-one (6-AziP), as a photoaffinity
labeling reagent to identify neuroactive steroid binding sites in rat
brain. 6-AziP is an effective modulator of GABAA receptors
as evidenced by its ability to inhibit binding of
[35S]t-butylbicyclophosphorothionate
to rat brain membranes and to potentiate GABA-elicited currents in
Xenopus oocytes and human endothelial kidney 293 cells expressing GABAA receptor subunits ( 1 2 2).
[3H]6-AziP produced time- and
concentration-dependent photolabeling of protein bands of ~35
and 60 kDa in rat brain membranes. The 35-kDa band was half-maximally
labeled at a [3H]6-AziP concentration of 1.9 µM, whereas the 60-kDa band was labeled at higher
concentrations. The photolabeled 35-kDa protein was isolated from rat
brain by two-dimensional PAGE and identified as
voltage-dependent anion channel-1 (VDAC-1) by both
matrix-assisted laser desorption ionization time-of-flight and
ESI-tandem mass spectrometry. Monoclonal antibody directed
against the N terminus of VDAC-1 immunoprecipitated labeled 35-kDa
protein from a lysate of rat brain membranes, confirming that VDAC-1 is
the species labeled by [3H]6-AziP. The 2
and 3 subunits of the GABAA receptor were
co-immunoprecipitated by the VDAC-1 antibody suggesting a physical
association between VDAC-1 and GABAA receptors in rat brain
membranes. These data suggest that neuroactive steroid effects on the
GABAA receptor may be mediated by binding to an accessory
protein, VDAC-1.
*
This work was supported in part by National Institutes of
Health Grants PO1-GM47969 (to J. H. S., D. F. C., and A. S. E.) and AA12952 (to S. J. M.) and by a grant from the Klingenstein Foundation (to S. J. M.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of
Anesthesiology, Washington University School of Medicine, 660 S. Euclid Ave., Campus Box 8054, St. Louis, MO 63110. Tel.: 314-454-8702; Fax:
314-454-5572; E-mail: eversa@notes.wustl.edu.
Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. R. Bracamontes and J. H. Steinbach
Multiple Modes for Conferring Surface Expression of Homomeric {beta}1 GABAA Receptors
J. Biol. Chem.,
September 19, 2008;
283(38):
26128 - 26136.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Bordet, B. Buisson, M. Michaud, C. Drouot, P. Galea, P. Delaage, N. P. Akentieva, A. S. Evers, D. F. Covey, M. A. Ostuni, et al.
Identification and Characterization of Cholest-4-en-3-one, Oxime (TRO19622), a Novel Drug Candidate for Amyotrophic Lateral Sclerosis
J. Pharmacol. Exp. Ther.,
August 1, 2007;
322(2):
709 - 720.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Schumacher, R. Guennoun, A. Ghoumari, C. Massaad, F. Robert, M. El-Etr, Y. Akwa, K. Rajkowski, and E.-E. Baulieu
Novel Perspectives for Progesterone in Hormone Replacement Therapy, with Special Reference to the Nervous System
Endocr. Rev.,
June 1, 2007;
28(4):
387 - 439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. P. Bright, S. D. Adham, L. C. J. M. Lemaire, R. Benavides, M. Gruss, G. W. Taylor, E. H. Smith, and N. P. Franks
Identification of Anesthetic Binding Sites on Human Serum Albumin Using a Novel Etomidate Photolabel
J. Biol. Chem.,
April 20, 2007;
282(16):
12038 - 12047.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Roman, J. Figys, G. Steurs, and M. Zizi
Hunting Interactomes of a Membrane Protein: Obtaining the Largest Set of Voltage-Dependent Anion Channel-Interacting Protein Epitopes
Mol. Cell. Proteomics,
September 1, 2006;
5(9):
1667 - 1680.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Xi, R. Liu, G. R. Asbury, M. F. Eckenhoff, and R. G. Eckenhoff
Inhalational Anesthetic-binding Proteins in Rat Neuronal Membranes
J. Biol. Chem.,
May 7, 2004;
279(19):
19628 - 19633.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Darbandi-Tonkabon, B. D. Manion, W. R. Hastings, W. J. Craigen, G. Akk, J. R. Bracamontes, Y. He, T. V. Sheiko, J. H. Steinbach, S. J. Mennerick, et al.
Neuroactive Steroid Interactions with Voltage-Dependent Anion Channels: Lack of Relationship to GABAA Receptor Modulation and Anesthesia
J. Pharmacol. Exp. Ther.,
February 1, 2004;
308(2):
502 - 511.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|